• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质性膀胱炎患者膀胱内注射透明质酸治疗后的膀胱镜检查结果变化

Changes in Cystoscopic Findings after Intravesical Hyaluronic Acid Instillation Therapy in Patients with Interstitial Cystitis.

作者信息

Lin Chia-Ju, Liu Chih-Ku, Hsieh Hsiao-Yun, Chen Ming-Jer, Tsai Ching-Pei

机构信息

Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.

出版信息

Diagnostics (Basel). 2022 Aug 19;12(8):2009. doi: 10.3390/diagnostics12082009.

DOI:10.3390/diagnostics12082009
PMID:36010358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9407291/
Abstract

(1) Background: Limited data showed changes in glomerulation in the bladder mucosa of patients with interstitial cystitis (IC) after intravesical hyaluronic acid (HA) bladder infusion. We aimed to investigate the above changes. (2) Methods: Medical records of IC patients were reviewed retrospectively, from January 2010 to October 2019. Patients who had received repeated cystoscopy after intravesical HA treatment were enrolled. The associations of multiple parameters, including the ages, symptoms, initial glomerulation stage, HA doses, and the interval period of repeated cystoscopy between the glomerulation change in the repeated cystoscopy were analyzed. (3) Results: Among the 35 patients, 9 cases (25.7%) showed better glomerulation grades in the repeated cystoscope (Group 1), 20 cases (57.1%) showed the same grades (Group 2), and 6 cases showed worse grades (Group 3). No difference was seen in the initial grades or treatment course among the three groups. The interval periods from the initial to the repeated cystoscopy of Group 1 were longer than Group 2 and Group 3 ( = 0.031). Group 3 presents an elder age trend than the other two groups. (4) Conclusion: Intravesical HA repaired bladder glomerulation in a small group of patients with IC. Prolonged treatment has potential benefits, while older age is possibly a negative factor. However, no strong correlation was found between the initial glomerulation grades or changes in glomerulation grades with clinical symptoms.

摘要

(1) 背景:有限的数据显示,膀胱内注入透明质酸(HA)后,间质性膀胱炎(IC)患者膀胱黏膜的肾小球化发生了变化。我们旨在研究上述变化。(2) 方法:回顾性分析2010年1月至2019年10月IC患者的病历。纳入接受膀胱内HA治疗后接受多次膀胱镜检查的患者。分析了多个参数之间的关联,包括年龄、症状、初始肾小球化阶段、HA剂量以及重复膀胱镜检查之间肾小球化变化的间隔时间。(3) 结果:35例患者中,9例(25.7%)在重复膀胱镜检查中显示肾小球化等级改善(第1组),20例(57.1%)显示等级相同(第2组),6例显示等级变差(第3组)。三组之间在初始等级或治疗过程方面未见差异。第1组从初始到重复膀胱镜检查的间隔时间长于第2组和第3组(P = 0.031)。第3组呈现出比其他两组年龄更大的趋势。(4) 结论:膀胱内HA修复了一小部分IC患者的膀胱肾小球化。延长治疗有潜在益处,而年龄较大可能是一个负面因素。然而,初始肾小球化等级或肾小球化等级变化与临床症状之间未发现强相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75b9/9407291/da021904fef4/diagnostics-12-02009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75b9/9407291/bfd5baa73894/diagnostics-12-02009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75b9/9407291/da021904fef4/diagnostics-12-02009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75b9/9407291/bfd5baa73894/diagnostics-12-02009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75b9/9407291/da021904fef4/diagnostics-12-02009-g002.jpg

相似文献

1
Changes in Cystoscopic Findings after Intravesical Hyaluronic Acid Instillation Therapy in Patients with Interstitial Cystitis.间质性膀胱炎患者膀胱内注射透明质酸治疗后的膀胱镜检查结果变化
Diagnostics (Basel). 2022 Aug 19;12(8):2009. doi: 10.3390/diagnostics12082009.
2
Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.膀胱镜下液压扩张特征为治疗后间质性膀胱炎的临床和长期预后特征提供了依据。
Sci Rep. 2021 Jan 11;11(1):455. doi: 10.1038/s41598-020-80252-x.
3
The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.膀胱内透明质酸治疗对间质性膀胱炎/膀胱疼痛综合征女性患者尿动力学和临床结局的影响。
Taiwan J Obstet Gynecol. 2020 Nov;59(6):922-926. doi: 10.1016/j.tjog.2020.09.021.
4
Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.膀胱内注射透明质酸溶液治疗难治性间质性膀胱炎/膀胱疼痛综合征后女性性功能的变化。
J Sex Med. 2014 Sep;11(9):2256-63. doi: 10.1111/jsm.12507. Epub 2014 Mar 17.
5
Low-pressure hydrodistension induces bladder glomerulations in female patients with interstitial cystitis/bladder pain syndrome.低压水扩张可诱发间质性膀胱炎/膀胱疼痛综合征女性患者出现膀胱肾小球样改变。
Neurourol Urodyn. 2022 Jan;41(1):296-305. doi: 10.1002/nau.24818. Epub 2021 Oct 11.
6
Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.透明质酸改善了间质性膀胱炎女性的疼痛症状,甚于改善其膀胱储尿症状。
Taiwan J Obstet Gynecol. 2019 May;58(3):417-422. doi: 10.1016/j.tjog.2018.11.033.
7
Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis.膀胱内注射透明质酸和碱化利多卡因治疗重度疼痛性膀胱综合征/间质性膀胱炎。
Int Urogynecol J. 2012 Dec;23(12):1715-20. doi: 10.1007/s00192-012-1802-3. Epub 2012 May 11.
8
Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndrome.预处理特征对膀胱内透明质酸灌注治疗难治性间质性膀胱炎/膀胱疼痛综合征疗效的影响。
Int Neurourol J. 2014 Sep;18(3):163-7. doi: 10.5213/inj.2014.18.3.163. Epub 2014 Sep 24.
9
Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis.膀胱内注射透明质酸可延长严重间质性膀胱炎患者膀胱水扩张的疗效。
Urology. 2010 Mar;75(3):547-50. doi: 10.1016/j.urology.2009.09.078.
10
Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.透明质酸治疗后间质性膀胱炎/膀胱疼痛综合征女性的泌尿及心理结局
Taiwan J Obstet Gynecol. 2018 Jun;57(3):360-363. doi: 10.1016/j.tjog.2018.04.006.

引用本文的文献

1
Intravesical Instillation of Hyaluronic Acid With Epidermal Growth Factor for Restoring Urothelial Denudation and Alleviating Oxidative Stress in Lipopolysaccharide-Induced Interstitial Cystitis of Rats.膀胱内灌注透明质酸联合表皮生长因子对恢复大鼠脂多糖诱导的间质性膀胱炎中尿路上皮剥脱及减轻氧化应激的作用
Int Neurourol J. 2024 Jun;28(2):106-114. doi: 10.5213/inj.2448028.014. Epub 2024 Jun 30.
2
Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome; Management: Research Advances, Experimental Targets, and Future Directions.泌尿外科慢性盆腔疼痛综合征的治疗方法;管理:研究进展、实验靶点及未来方向。
J Pharmacol Exp Ther. 2024 Jul 18;390(2):222-232. doi: 10.1124/jpet.123.002081.
3

本文引用的文献

1
Improved symptoms and signs of refractory interstitial cystitis in women after intravesical Nanofat plus platelet-rich plasma grafting: A pilot study.经膀胱内纳米脂肪联合富血小板血浆移植后,女性难治性间质性膀胱炎的症状和体征得到改善:一项初步研究。
J Chin Med Assoc. 2022 Jun 1;85(6):730-735. doi: 10.1097/JCMA.0000000000000735. Epub 2022 Jun 10.
2
Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.膀胱镜下液压扩张特征为治疗后间质性膀胱炎的临床和长期预后特征提供了依据。
Sci Rep. 2021 Jan 11;11(1):455. doi: 10.1038/s41598-020-80252-x.
3
The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Cystoscopic characteristic findings of interstitial cystitis and clinical implications.
间质性膀胱炎的膀胱镜特征性表现及临床意义。
Tzu Chi Med J. 2023 Aug 22;36(1):30-37. doi: 10.4103/tcmj.tcmj_172_23. eCollection 2024 Jan-Mar.
4
The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans.用于评估人类间质性再生新分子策略的间质性膀胱炎模型。
Int J Mol Sci. 2024 Feb 15;25(4):2326. doi: 10.3390/ijms25042326.
5
Glycosaminoglycan Replacement Therapy with Intravesical Instillations of Combined Hyaluronic Acid and Chondroitin Sulfate in Patients with Recurrent Cystitis, Post-radiation Cystitis and Bladder Pain Syndrome: A Narrative Review.透明质酸与硫酸软骨素联合膀胱灌注的糖胺聚糖替代疗法治疗复发性膀胱炎、放射性膀胱炎和膀胱疼痛综合征患者:一项叙述性综述
Pain Ther. 2024 Feb;13(1):1-22. doi: 10.1007/s40122-023-00559-1. Epub 2023 Nov 2.
膀胱内透明质酸治疗对间质性膀胱炎/膀胱疼痛综合征女性患者尿动力学和临床结局的影响。
Taiwan J Obstet Gynecol. 2020 Nov;59(6):922-926. doi: 10.1016/j.tjog.2020.09.021.
4
New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome - Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave.间质性膀胱炎/膀胱疼痛综合征的治疗新前沿——聚焦于干细胞、富血小板血浆和低能量冲击波
Int Neurourol J. 2020 Sep;24(3):211-221. doi: 10.5213/inj.2040104.052. Epub 2020 Sep 30.
5
Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.透明质酸改善了间质性膀胱炎女性的疼痛症状,甚于改善其膀胱储尿症状。
Taiwan J Obstet Gynecol. 2019 May;58(3):417-422. doi: 10.1016/j.tjog.2018.11.033.
6
Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model.膀胱内透明质酸治疗对间质性膀胱炎大鼠模型膀胱炎症的影响。
Int Braz J Urol. 2018 Sep-Oct;44(5):1014-1022. doi: 10.1590/S1677-5538.IBJU.2017.0713.
7
Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).膀胱疼痛综合征(BPS)/间质性膀胱炎(IC)膀胱内治疗的进展
Low Urin Tract Symptoms. 2018 Jan;10(1):3-11. doi: 10.1111/luts.12214.
8
Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment.评估间质性膀胱炎/膀胱疼痛综合征持续性频率的发生率和相关风险因素,以及抗毒蕈碱治疗的疗效。
Investig Clin Urol. 2017 Sep;58(5):353-358. doi: 10.4111/icu.2017.58.5.353. Epub 2017 Aug 3.
9
Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.无 Hunner 病变间质性膀胱炎/膀胱疼痛综合征的组织病理学特征。
Histopathology. 2017 Sep;71(3):415-424. doi: 10.1111/his.13235. Epub 2017 Jun 16.
10
A survey on clinical practice of interstitial cystitis in Japan.日本间质性膀胱炎临床实践调查
Transl Androl Urol. 2015 Oct;4(5):486-90. doi: 10.3978/j.issn.2223-4683.2015.08.06.